Follow Us

Johnson & Johnson to Begin COVID-19 Vaccine Trials On Humans In July

Johnson & Johnson says it will begin to test a coronavirus vaccine on 1,045 healthy adults.

Johnson & Johnson to Begin COVID-19 Vaccine Trials On Humans In July

AP / Sakchai Lalit

Posted: 2:22 p.m. EDT Jun 10, 2020

Johnson & Johnson announced it would begin human trials for its coronavirus vaccine in July.

The company said Wednesday its trials will begin two months ahead of schedule due to the "strength" of results from research so far.

Johnson & Johnson's pharmaceutical division plans to test 1,045 healthy adults in the U.S. and Belgium, giving some the vaccine and some a placebo.

Should the vaccine be successful, the company is seeking to provide one billion units of it throughout 2021.

Johnson & Johnson is one of 10 companies attempting to find a safe and effective vaccine for the coronavirus, according to Reuters. While some companies have begun human trials, many experts have said that a vaccine could take 12 to 18 months to develop.

Top Stories

A thunderstorm passes over Kansas City

Storms threaten hail and tornadoes, starting in plains states

The National Weather Service's Storm Prediction Center forecast hail, flash floods and possible tornadoes in Kansas and Nebraska.

A woman and her dog nap in a park.

Feel like you're not getting enough sleep? You're not alone, poll says

A Gallup poll found 57% of Americans think more sleep could improve their state of being, which is a stark difference from its previous data.

The River Seine in Paris, France.

France has contingencies in case of security risks at Olympic ceremony

France expects to hold the games' opening ceremony in an unusual open-air setting on the River Seine, which may bring unique security problems.